Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 798 | 927 | 1,486 | 2,544 | 752 |
| Cost of Goods | N/A | N/A | 8 | 8 | 12 |
| Gross Profit | 798 | 927 | 1,478 | 2,536 | 740 |
| Operating Expenses | 17,391 | 15,497 | 12,506 | 8,490 | 8,874 |
| Operating Income | -16,593 | -14,570 | -11,020 | -5,946 | -8,122 |
| Other Income | 287 | 257 | 348 | 193 | -14 |
| Pre-tax Income | -16,306 | -14,313 | -10,672 | -5,753 | -8,136 |
| Income Tax | 81 | 71 | 159 | 51 | 57 |
| Net Income Continuous | -16,387 | -14,384 | -10,831 | -5,804 | -8,193 |
| Net Income | $-16,387 | $-14,384 | $-10,831 | $-5,804 | $-8,193 |
| EPS Basic Total Ops | -0.44 | -0.39 | -0.30 | -0.19 | -0.27 |
| EPS Basic Continuous Ops | -0.44 | -0.39 | -0.31 | -0.19 | -0.27 |
| EPS Diluted Total Ops | -0.44 | -0.39 | -0.30 | -0.19 | -0.27 |
| EPS Diluted Continuous Ops | -0.44 | -0.39 | -0.31 | -0.19 | -0.27 |
| EBITDA(a) | $-16,546 | $-14,526 | $-10,980 | $-5,909 | $-8,086 |